PALO ALTO, Calif., April 3, 2014 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) announced today that its management will hold a mid-year review for investors from 11:30 a.m. through 1:30 p.m. on May 6, 2014 at The Westin New York Grand Central, 212 E. 42nd St, New York. Management presentations will cover financial performance through the first half of fiscal year 2014, strategic initiatives, and growth opportunities in markets for oncology systems and x-ray imaging.
Varian management at the meeting will include: Dow Wilson, CEO; Kolleen Kennedy, Senior Vice President and President of Oncology Systems; Elisha Finney, Executive Vice President and CFO; Sunny Sanyal, Senior Vice President and President of Imaging Components Business; and Spencer Sias, Vice President of Corporate Communications and Investor Relations.
To attend, please RSVP to Anne Rambo at anne.rambo@varian.com or by calling 650-424-5834.
The meeting and presentations will be webcast and may be accessed via the company website at www.varian.com/investor. Web conferences will be archived on the company website for a year. Additional information about Varian Medical Systems can be obtained on the company's website. Investors can subscribe to receive automatic "e-mail alerts" regarding Varian news and events via the company website at www.varian.com/investor.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,400 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.
FOR INFORMATION CONTACT:
Spencer Sias, (650) 424-5782
Vice President, Corporate Communications
and Investor Relations
spencer.sias@varian.com
SOURCE Varian Medical Systems